Met Life Investment Management, LLC Accolade, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Accolade, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 37,069 shares of ACCD stock, worth $128,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,069
Previous 43,322
14.43%
Holding current value
$128,629
Previous $155,000
8.39%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ACCD
# of Institutions
171Shares Held
67.6MCall Options Held
181KPut Options Held
1.66M-
Black Rock Inc. New York, NY6.16MShares$21.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.38MShares$18.7 Million0.2% of portfolio
-
Brown Advisory Inc4.82MShares$16.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.16MShares$14.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.99MShares$13.8 Million0.01% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $250M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...